{
 "name": "冠亞",
 "slug": "tw-6758",
 "aliases": [
  "冠亞生技股份有限公司",
  "ASA",
  "6758"
 ],
 "ticker": "6758",
 "industry": "生技醫療業",
 "website": "http://www.aspine.com.tw",
 "summary": "冠亞（6758）是興櫃的生技醫療類股公司，2001 年成立，2020 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "冠亞生技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "ASA",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2020-01-02",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2001-06-15",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "林延生",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "薛好娟",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 134710400,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "安永聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "http://www.aspine.com.tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：WinLoc",
   "value": "脊椎固定（未逐項揭露適用節段）｜年報列現有自製脊椎固定系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "113年度年報實體第40頁產品表；多項產品共同用途，不推定逐品項藥證或2026年上市狀態。"
  },
  {
   "claim": "管線：CervoLoc",
   "value": "脊椎固定（未逐項揭露適用節段）｜年報列現有自製脊椎固定系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "113年度年報實體第40頁產品表；多項產品共同用途，不推定逐品項藥證或2026年上市狀態。"
  },
  {
   "claim": "管線：SmartLoc Evo",
   "value": "脊椎固定（未逐項揭露適用節段）｜年報列現有自製脊椎固定系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "113年度年報實體第40頁產品表；多項產品共同用途，不推定逐品項藥證或2026年上市狀態。"
  },
  {
   "claim": "管線：SmartLoc Omega",
   "value": "脊椎固定（未逐項揭露適用節段）｜年報列現有自製脊椎固定系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "113年度年報實體第40頁產品表；多項產品共同用途，不推定逐品項藥證或2026年上市狀態。"
  },
  {
   "claim": "管線：SmartMIS",
   "value": "脊椎固定（未逐項揭露適用節段）｜年報列現有自製脊椎固定系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "113年度年報實體第40頁產品表；多項產品共同用途，不推定逐品項藥證或2026年上市狀態。"
  },
  {
   "claim": "管線：ASA",
   "value": "脊椎固定（未逐項揭露適用節段）｜年報列現有自製脊椎固定系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "113年度年報實體第40頁產品表；多項產品共同用途，不推定逐品項藥證或2026年上市狀態。"
  },
  {
   "claim": "管線：Combo頸椎椎間融合器",
   "value": "椎間融合與脊椎穩定｜年報列現有自製脊椎融合系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "113年度年報實體第40頁產品表；未將產品目錄等同逐地區核准。"
  },
  {
   "claim": "管線：Combo腰椎椎間融合器",
   "value": "椎間融合與脊椎穩定｜年報列現有自製脊椎融合系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "113年度年報實體第40頁產品表；未將產品目錄等同逐地區核准。"
  },
  {
   "claim": "管線：高分子複合材料頸椎及腰椎融合器",
   "value": "椎間融合與脊椎穩定｜年報列現有自製脊椎融合系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "113年度年報實體第40頁產品表；未將產品目錄等同逐地區核准。"
  },
  {
   "claim": "管線：Redmond Cervical Implants",
   "value": "椎間融合與脊椎穩定｜年報列現有自製脊椎融合系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "113年度年報實體第40頁產品表；未將產品目錄等同逐地區核准。"
  },
  {
   "claim": "管線：Redmond Lumbar Cage",
   "value": "椎間融合與脊椎穩定｜年報列現有自製脊椎融合系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "113年度年報實體第40頁產品表；未將產品目錄等同逐地區核准。"
  },
  {
   "claim": "管線：ASTA Cervical Interbody Fusion Cage",
   "value": "椎間融合與脊椎穩定｜年報列現有自製脊椎融合系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "113年度年報實體第40頁產品表；未將產品目錄等同逐地區核准。"
  },
  {
   "claim": "管線：AVALON椎體撐開器",
   "value": "椎體撐開與骨水泥注入穩定椎體｜年報列現有骨填充系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "刊印日期2025-05-09；產品表第40頁。"
  },
  {
   "claim": "管線：A-Mesh鈦網",
   "value": "椎體支撐｜年報列現有椎體置換系統｜未逐項揭露地區",
   "unit": "",
   "as_of": "2025-05-09",
   "source": "https://www.aspine.com.tw/storage/system/Investor/CA114.pdf",
   "note": "刊印日期2025-05-09；產品表第40頁，非藥物。"
  }
 ],
 "provided_by": "public_sources",
 "verified_at": "2026-10-22",
 "url": "https://drugnews.com.tw/companies/tw-6758.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}